Abstract
Recent evidence suggests that patients with chronic inflammatory disorders are at increased cardiovascular risk. A number of different mechanisms have been postulated to contribute to atherosclerotic disease progression in these patients including traditional cardiovascular risk factors, cytokine upregulation, immume mediated pathways and increased oxidative stress. Novel treatments target inflammatory pathways and have beneficial effect on rheumatic disease activity however; their impact on cardiovascular risk reduction remains unclear. Further longitudinal studies are required to assess the value of different therapeutic approaches on cardiovascular outcome of these patients.
Keywords: Inflammatory disorders, rheumatoid, lupus, drugs, antiphospholipid, cardiovascular risk, apoptosis, oxidative stress, atherosclerosis, cytokines
Current Pharmaceutical Design
Title: Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches
Volume: 17 Issue: 37
Author(s): Marietta Charakida, Frank O'Neil, Stefano Masi, Nikolaos Papageorgiou and Dimitris Tousoulis
Affiliation:
Keywords: Inflammatory disorders, rheumatoid, lupus, drugs, antiphospholipid, cardiovascular risk, apoptosis, oxidative stress, atherosclerosis, cytokines
Abstract: Recent evidence suggests that patients with chronic inflammatory disorders are at increased cardiovascular risk. A number of different mechanisms have been postulated to contribute to atherosclerotic disease progression in these patients including traditional cardiovascular risk factors, cytokine upregulation, immume mediated pathways and increased oxidative stress. Novel treatments target inflammatory pathways and have beneficial effect on rheumatic disease activity however; their impact on cardiovascular risk reduction remains unclear. Further longitudinal studies are required to assess the value of different therapeutic approaches on cardiovascular outcome of these patients.
Export Options
About this article
Cite this article as:
Charakida Marietta, O'Neil Frank, Masi Stefano, Papageorgiou Nikolaos and Tousoulis Dimitris, Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches, Current Pharmaceutical Design 2011; 17 (37) . https://dx.doi.org/10.2174/138161211798764807
DOI https://dx.doi.org/10.2174/138161211798764807 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Osmolytes in Regulating Immune System
Current Pharmaceutical Design Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current Recommendations
Cardiovascular & Hematological Agents in Medicinal Chemistry Progress in Elucidating the Structural and Dynamic Character of G Protein-Coupled Receptor Oligomers for Use in Drug Discovery
Current Pharmaceutical Design Synthesis, Design and Anti-inflammatory Activity of Novel 5-(Indol-3- yl)thiazolidinone Derivatives as COX-2 Inhibitors
Letters in Drug Design & Discovery Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
Current Cancer Drug Targets Cardiovascular Toxicity from the Perspective of Oxidative Stress, Electron Transfer, and Prevention by Antioxidants
Current Vascular Pharmacology Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity Against Staphylococcus aureus Skin Infection
Current Medicinal Chemistry Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Drug Delivery & Formulation Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Current Neuropharmacology Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase
Current Drug Targets - Cardiovascular & Hematological Disorders Allergic Contact Dermatitis to Nickel: From Clinical Aspects to Therapeutic Measures
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Interaction of TGF-β with Immune Cells in Airway Disease
Current Molecular Medicine Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures
Current Medicinal Chemistry Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Methylene Blue and Vasoplegia: Who, When, and How?
Mini-Reviews in Medicinal Chemistry Management and Treatment of Dengue and Chikungunya - Natural Products to the Rescue
Combinatorial Chemistry & High Throughput Screening Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak
Mini-Reviews in Medicinal Chemistry Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
Current Neuropharmacology